Back to search results

Observational Study of Wearable Devices for Adolescent Suicide Risk

This study is looking at how data from a wearable wrist device, called Analog Devices Inc., might help identify when suicidal thoughts or feelings are getting worse in teenagers. The device collects information like heart rate and movement. Researchers hope this information can help mental health providers step in earlier to support adolescents aged 13-17 who have recently been to the emergency room or an inpatient psychiatric unit because of suicidal thoughts or attempts. The goal is to create a way to monitor these changes outside of the hospital and help prevent future crises. The study aims to enroll 144 participants.

Study design
This is an observational study, meaning participants will be monitored without receiving a specific treatment from the study. It plans to include 144 participants.
What's involved
Participants will wear a wrist device that collects data. Heart rate variability and suicidality will be measured four times daily for up to one week.
Compensation
Not stated in the trial record.
Follow-up
Participants will be monitored for heart rate variability and suicidality for up to one week.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06400810

Proximal Risk for Suicide in Adolescents

Recruiting
Not specifiedAges 13–17Observational
Oregon Health and Science University
~144 participants
Updated 2025-08-14 on ClinicalTrials.gov
What's tested:Analog Devices Inc.

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Heart rate variability and Suicidality
Measured over Four times daily up to one week
+1 more outcome measured

Conditions

Suicide
Mental Health Issue

Explore related trials

Suicide

Where it's being run

1 sites across 1 states
Oregon1

Study leadership

  • David Sheridan, MD · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University

Who to contact

David Sheridan, MD
[email protected]
503-494-1691
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

subjects aged 13-17 years
presenting to the ED or inpatient psychiatric unit with a chief complaint of acute suicidality or attempt.

Exclusion

acutely agitated patients per the treating physician
adolescents who are not medically cleared from a suicide attempt
no legally authorized representative available to provide consent
parental report of significant developmental delay or autism diagnosis
prisoners
non-English speaking.

What this trial measures

  • Heart rate variability and SuicidalityFour times daily up to one week

    Prediction of Suicidality outcome measured by the Columbia Suicide Severity scale (higher score means more suicidal)

  • Heart rate variability and SuicidalityFour times daily up to one week

    Prediction of Suicidality outcome measured by the High Frequency Heart Rate Variability Metric (lower score means less parasympathetic response)